Bio Solution Co Ltd banner
B

Bio Solution Co Ltd
KOSDAQ:086820

Watchlist Manager
Bio Solution Co Ltd
KOSDAQ:086820
Watchlist
Price: 11 800 KRW 1.64% Market Closed
Market Cap: ₩286.6B

Wall Street
Price Targets

Price Targets Summary
Bio Solution Co Ltd

There are no price targets for Bio Solution Co Ltd.
Lowest
Price Target
Not Available
Average
Price Target
Not Available
Highest
Price Target
Not Available
Bio Solution Co Ltd Competitors:
Price Targets
RLMD
Relmada Therapeutics Inc
109% Upside
TTD
Trade Desk Inc
60% Upside
KNSA
Kiniksa Pharmaceuticals Ltd
17% Upside
NSIT
Insight Enterprises Inc
55% Upside
TCPC
BlackRock TCP Capital Corp
18% Upside

Revenue
Forecast

14% / Year
Past Growth
47% / Year
Estimated Growth
N/A
Estimates Accuracy
N/A
Average
14% / Year
Past Growth
47% / Year
Estimated Growth
N/A
Estimates Accuracy
N/A
Average

For the last 7 years the compound annual growth rate for Bio Solution Co Ltd's revenue is 14%. The projected CAGR for the next 3 years is 47%.

Operating Income
Forecast

N/A
Past Growth
N/A
Estimated Growth
N/A
Estimates Accuracy
N/A
Average
N/A
Past Growth
N/A
Estimated Growth
N/A
Estimates Accuracy
N/A
Average

Net Income
Forecast

N/A
Past Growth
N/A
Estimated Growth
N/A
Estimates Accuracy
N/A
Average
N/A
Past Growth
N/A
Estimated Growth
N/A
Estimates Accuracy
N/A
Average
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is Bio Solution Co Ltd's stock price target?
Not Available

Bio Solution Co Ltd doesn't have any price targets made by Wall Street professionals.

What is Bio Solution Co Ltd's Revenue forecast?
Projected CAGR
47%

For the last 7 years the compound annual growth rate for Bio Solution Co Ltd's revenue is 14%. The projected CAGR for the next 3 years is 47%.

Back to Top
Get AI-powered insights for any company or topic.
Open AI Assistant

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett